3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
67
Breast
17
Gastrointestinal
16
Thoracic
13
Genitourinary
11
Sarcoma
10
Head & Neck
8
Dermatologic
6
Lymphoid
4
CNS
4
Other hematologic neoplasm
3
Plasma cell
2
Other solid neoplasm
1
Other neoplasm
1
Other
1
NET
1
Endocrine
1
Conditions
Advanced Solid Tumors
173
Advanced Solid Tumor
150
Solid Tumor
129
Mesothelioma
88
Mesothelioma, Malignant
81
Solid Tumors
79
Hematopoietic and Lymphatic System Neoplasm
47
Solid Tumor, Adult
35
Carcinoma, Non-Small-Cell Lung
32
Retinoblastoma
29
Ovarian Neoplasms
26
Melanoma
24
Colorectal Neoplasms
22
Pancreatic Neoplasms
21
Stomach Neoplasms
20
Sarcoma
20
Lung Neoplasms
19
Carcinoma, Renal Cell
18
Uterine Cervical Neoplasms
16
Esophageal Neoplasms
16
Neoplasms
15
Malignant Solid Neoplasm
15
Neoplasm Metastasis
14
Hematopoietic and Lymphoid System Neoplasm
14
Advanced or Metastatic Solid Tumors
14
Triple Negative Breast Neoplasms
13
Solid Tumor Malignancies
13
Small Cell Lung Carcinoma
13
Advanced Malignant Solid Tumor
13
Urinary Bladder Neoplasms
12
Interventions
pembrolizumab
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Other solid neoplasm
×
1 year
×
Clear all
NCT05579366
2026-06-03
RAINFOL-01
Genmab
Phase 1/2
Recruiting
884 enrolled